Advertisement

Topics

FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia

15:00 EDT 16 May 2019 | Drugs.com

THURSDAY, May 16, 2019 -- Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday. Data from CLL14, a...

Original Article: FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia"

Advertisement
Quick Search
Advertisement
Advertisement